Search Results 1451-1460 of 28617 for oral

1. Pioglitazone and glimepiride (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For type 2 diabetes: For patients already taking glimepiride alone: Adults—At first, 1 tablet (either pioglitazone 30 ...

2. Study Evaluating the Safety and Efficacy of Fenfluramine Hydrochloride Oral Solution as Adjunctive Therapy in Children with Doose Syndrome - Mayo Clinic

   Study Evaluating the Safety and Efficacy of Fenfluramine Hydrochloride Oral Solution as Adjunctive Therapy in Children with Doose Syndrome · Share · Facebook ...

3. Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio

   Kevin Arce, an oral and maxillofacial surgeon at Mayo Clinic, will discuss reconstructive surgery for oral cancer patients. Here's your Mayo Clinic Radio ...

4. A Study Evaluating the Effectiveness of Oral Vismodegib in Various Histologic Subtypes of High Risk or Locally Advanced Basal Cell Carcinoma - Mayo Clinic

   The purpose of this study is to investigate the safety and effectiveness of oral vismodegib therapy in the treatment of different 'histologic subtypes' of basal ...

5. Athlete's foot - Diagnosis and treatment - Mayo Clinic

   Or you might need both topical and oral medicine. Request an appointment. There is a problem with information submitted for this request. Review/update the ...

6. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

   TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against ...

7. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   ... Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3). Participation eligibility. Participant ...

8. Vorasidenib (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For treatment of brain tumor: Adults and children 12 years of age and older weighing 40 kilograms (kg) or more—40 milligrams ...

9. A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors - Mayo Clinic

   A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors · Share · Facebook · Twitter.

10. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...